Skip to content

Intradermal acupuncture for the breast cancer-related insomnia: a clinical randomized controlled study

Intradermal acupuncture for the breast cancer-related insomnia: a clinical randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075258
Enrollment
Unknown
Registered
2023-08-31
Start date
2023-08-31
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer-related insomnia

Interventions

Treatment Group:Intradermal acupuncture
Control Group:Sham intradermal acupuncture

Sponsors

Tianjin Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (?) females aged =18 with a diagnosis of breast cancer; (?)Insomnia symptoms (difficulty falling asleep and/or maintaining sleep): Duration >4 weeks and occurring at least 3 times per week, with the fulfilment of the diagnostic criteria for insomnia disorder in cancer patients published by the National Comprehensive Cancer Network (NCCN); the severity of insomnia reached at least 10 points of Insomnia Severity Index (ISI) over the past 2 weeks; (?) Expected survival =6 months; (?)Eastern Cooperative Oncology Group (ECOG) Performance Status=1; and (?) Voluntarily participated in this study and signed an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients undergoing surgery, chemotherapy, radiation, or reconstructive plastic surgery during the study period; (2) Advanced breast cancer patients with evidence of recurrence or metastasis; (3) Patients with serious diseases of cardiovascular and cerebrovascular, liver, kidney, hematopoietic system and serious mental diseases; (4) Pregnant, lactating or pregnant patients; (5) Patients who are allergic to stainless steel or have skin infections or ulcers in the acupoint area; (6) Patients currently receiving acupuncture treatment; (7) Have mental or intellectual disabilities, can not self-judge sleep status, can not independently complete the scale; (8)Participating in other clinical trials of behavioral, psychological, pharmaceutical or complementary medicine interventions; (9) Irregular use of barbiturates, antidepressants or other sleep AIDS (including Chinese medicine); (10) Addiction to caffeine, alcohol or psychotropic drugs; (11) Patients with insomnia whose total sleep duration is less than 4h.

Design outcomes

Primary

MeasureTime frame
Insomnia Severity Index;

Secondary

MeasureTime frame
Sleep Diary;the Pittsburgh Sleep Quality Index;the Hospital Anxiety and Depression Scale;Brief Fatigue Inventory;the Patient-Reported Outcomes Measurement Information System Global Health Scale;

Countries

China

Contacts

Public ContactBo Chen;Bin Wang

Tianjin University of Traditional Chinese Medicine / Tianjin Cancer Hospital

tjutcmchenbo@163.com+86 135 1246 2440

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026